{"id":"https://openalex.org/W2267701923","doi":null,"title":"A Phase I dose-escalation study of the BRAF inhibitor vemurafenib in combination with the MTOR inhibitor everolimus in subjects with advanced cancer","display_name":"A Phase I dose-escalation study of the BRAF inhibitor vemurafenib in combination with the MTOR inhibitor everolimus in subjects with advanced cancer","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2267701923","mag":"2267701923"},"language":"en","primary_location":{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1650","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","pdf_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090442154","display_name":"Javier L Munoz","orcid":"https://orcid.org/0000-0002-9060-8911","observed_orcids":["https://orcid.org/0000-0002-9060-8911"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Javier Mu\u00f1oz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9060-8911","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5090442154"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.029500000178813934,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":1.0},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.7929999828338623},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8130000233650208},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.46799999475479126},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8399999737739563},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8460000157356262},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9398360252380371},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8921668529510498},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7498663067817688},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7132036089897156},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.6083836555480957},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5944370031356812},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5122827887535095},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.44824159145355225},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.429858922958374},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41919487714767456},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4148268699645996},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3698752522468567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3296831548213959},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.2035040557384491},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.16776692867279053},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11869555711746216},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.11147230863571167},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1650","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","pdf_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},{"id":"mag:2267701923","doi":null,"is_oa":false,"landing_page_url":"http://digitalcommons.library.tmc.edu/cgi/viewcontent.cgi?article=1650&context=utgsbs_dissertations","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1650","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","pdf_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/614","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2267701923.pdf","grobid_xml":"https://content.openalex.org/works/W2267701923.grobid-xml"},"referenced_works_count":135,"referenced_works":["https://openalex.org/W1487917997","https://openalex.org/W1488372279","https://openalex.org/W1496529448","https://openalex.org/W1538981488","https://openalex.org/W1565041471","https://openalex.org/W1569559112","https://openalex.org/W1582018541","https://openalex.org/W1599750485","https://openalex.org/W1914707730","https://openalex.org/W1965252168","https://openalex.org/W1966738726","https://openalex.org/W1971947883","https://openalex.org/W1975411977","https://openalex.org/W1989121777","https://openalex.org/W1990011632","https://openalex.org/W1994225895","https://openalex.org/W1997232062","https://openalex.org/W2001258296","https://openalex.org/W2001710734","https://openalex.org/W2001999652","https://openalex.org/W2002696404","https://openalex.org/W2002792806","https://openalex.org/W2004295816","https://openalex.org/W2005383654","https://openalex.org/W2005508652","https://openalex.org/W2006268804","https://openalex.org/W2006345374","https://openalex.org/W2006741643","https://openalex.org/W2011699883","https://openalex.org/W2011755139","https://openalex.org/W2012558297","https://openalex.org/W2014250484","https://openalex.org/W2015682571","https://openalex.org/W2017187984","https://openalex.org/W2017375813","https://openalex.org/W2020773732","https://openalex.org/W2027620575","https://openalex.org/W2032211985","https://openalex.org/W2034048944","https://openalex.org/W2035001481","https://openalex.org/W2040059660","https://openalex.org/W2040429996","https://openalex.org/W2040760628","https://openalex.org/W2043058822","https://openalex.org/W2044029217","https://openalex.org/W2048765718","https://openalex.org/W2048878689","https://openalex.org/W2049171090","https://openalex.org/W2051841073","https://openalex.org/W2052531634","https://openalex.org/W2052811553","https://openalex.org/W2057698420","https://openalex.org/W2057731311","https://openalex.org/W2061393391","https://openalex.org/W2061889123","https://openalex.org/W2062493935","https://openalex.org/W2065703106","https://openalex.org/W2067955480","https://openalex.org/W2069682021","https://openalex.org/W2073363047","https://openalex.org/W2073683003","https://openalex.org/W2077517114","https://openalex.org/W2077858999","https://openalex.org/W2079641245","https://openalex.org/W2080549930","https://openalex.org/W2083695927","https://openalex.org/W2085959481","https://openalex.org/W2088293068","https://openalex.org/W2089228335","https://openalex.org/W2091100650","https://openalex.org/W2092286514","https://openalex.org/W2092800497","https://openalex.org/W2093691792","https://openalex.org/W2096223992","https://openalex.org/W2096540669","https://openalex.org/W2097762752","https://openalex.org/W2100614336","https://openalex.org/W2101035019","https://openalex.org/W2102646127","https://openalex.org/W2104694028","https://openalex.org/W2106484137","https://openalex.org/W2106494998","https://openalex.org/W2106726562","https://openalex.org/W2109478314","https://openalex.org/W2111004422","https://openalex.org/W2111404068","https://openalex.org/W2111778006","https://openalex.org/W2114446999","https://openalex.org/W2114784462","https://openalex.org/W2116386978","https://openalex.org/W2117765751","https://openalex.org/W2120748646","https://openalex.org/W2124378682","https://openalex.org/W2128542677","https://openalex.org/W2131967786","https://openalex.org/W2132757216","https://openalex.org/W2132798879","https://openalex.org/W2134490812","https://openalex.org/W2135131549","https://openalex.org/W2135881334","https://openalex.org/W2135925159","https://openalex.org/W2136076252","https://openalex.org/W2136474966","https://openalex.org/W2136925048","https://openalex.org/W2137036286","https://openalex.org/W2137549398","https://openalex.org/W2139720565","https://openalex.org/W2140998787","https://openalex.org/W2141674733","https://openalex.org/W2141830999","https://openalex.org/W2144096834","https://openalex.org/W2145098718","https://openalex.org/W2145455579","https://openalex.org/W2149000868","https://openalex.org/W2149159811","https://openalex.org/W2149662085","https://openalex.org/W2153105757","https://openalex.org/W2153938645","https://openalex.org/W2154841567","https://openalex.org/W2155381255","https://openalex.org/W2156078931","https://openalex.org/W2156266404","https://openalex.org/W2157144029","https://openalex.org/W2158833600","https://openalex.org/W2159594827","https://openalex.org/W2160304102","https://openalex.org/W2163188200","https://openalex.org/W2163563579","https://openalex.org/W2164996207","https://openalex.org/W2165651085","https://openalex.org/W2166262263","https://openalex.org/W2167997534","https://openalex.org/W2170013888","https://openalex.org/W2171367970","https://openalex.org/W2326876692"],"related_works":["https://openalex.org/W2477067724","https://openalex.org/W2639536160","https://openalex.org/W2890706095","https://openalex.org/W2898658893","https://openalex.org/W2149642154","https://openalex.org/W2600188869","https://openalex.org/W2428197444","https://openalex.org/W3096898172","https://openalex.org/W2289997218","https://openalex.org/W2605280237"],"abstract_inverted_index":{"Vemurafenib":[0],"has":[1],"been":[2],"approved":[3],"in":[4,24,37,112,121],"the":[5,9,57,64,68,84,90,93],"United":[6],"States":[7],"for":[8],"treatment":[10],"of":[11,56,67,70,92,95,115,124,136,148],"relapsed":[12],"or":[13],"refractory":[14],"BRAF":[15],"mutation":[16],"positive":[17],"malignant":[18],"melanoma":[19,111],"and":[20,72,89,97,143],"is":[21,32,81],"being":[22],"investigated":[23],"various":[25],"other":[26],"malignancies.":[27],"The":[28,41,78,106,128],"RAS/RAF/MEK/ERK":[29],"(MAPK)":[30],"pathway":[31],"critical":[33],"to":[34,47,82],"cell":[35],"proliferation":[36],"many":[38],"human":[39],"cancers.":[40],"mTOR":[42],"inhibitors":[43],"are":[44],"well":[45,76],"known":[46],"exert":[48],"profound":[49],"anticancer":[50],"effects":[51],"across":[52],"malignancies":[53],"through":[54],"inhibition":[55],"PTEN/PI3K/AKT/mTOR":[58],"(mTOR)":[59],"pathway.":[60],"We":[61],"hypothesize":[62],"that":[63],"toxicity":[65,91],"profile":[66],"combination":[69,94],"vemurafenib":[71,96],"everolimus":[73,98],"will":[74],"be":[75],"tolerated.":[77],"primary":[79],"objective":[80],"find":[83],"maximum":[85],"tolerated":[86],"dose":[87],"(MTD)":[88],"following":[99],"a":[100],"standard":[101],"3":[102,104],"+":[103],"design.":[105],"most":[107],"common":[108],"diagnosis":[109],"was":[110,131],"5":[113],"out":[114,123,135,147],"10":[116,125,137,149],"patients":[117,120,126,138,150],"(50%).":[118],"Male":[119],"7":[122],"(70%).":[127],"average":[129],"age":[130],"63.5":[132],"years.":[133],"Two":[134],"(20%)":[139,151],"had":[140,152],"partial":[141],"responses":[142],"an":[144],"additional":[145],"2":[146],"stable":[153],"disease.":[154]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}